Avadel Pharma (AVDL) Misses Q2 EPS by 65c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq falls as Alphabet set for record loss amid AI spending woes
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts AVDL Hot Sheet
Join SI Premium – FREE
Avadel Pharma (NASDAQ: AVDL) reported Q2 EPS of ($1.07), $0.65 worse than the analyst estimate of ($0.42).
For earnings history and earnings-related data on Avadel Pharma (AVDL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aon CEO warns AI data centers carry insurance risks
- Coastal Financial Corporation (CCB) Misses Q3 EPS by 7c
- TAL International (TAL) PT Lowered to $11.50 at Jefferies
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
